Clinical Roundup Taletrectinib shrinks tumors in NSCLC indication in phase II trial October 27, 2023Vol.49 No.40
Clinical Roundup Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancer October 27, 2023Vol.49 No.40
Clinical Roundup PFAS forever chemicals could be a risk factor in thyroid cancer, Mount Sinai researchers find October 27, 2023Vol.49 No.40
Clinical Roundup USC study reveals how exposure to racial discrimination can impact health care for Black cancer patients October 27, 2023Vol.49 No.40
Clinical Roundup Cedars-Sinai researchers find two potential treatments that improve outcomes in recurrent prostate cancer October 27, 2023Vol.49 No.40
Clinical Roundup Five-year monarchE outcome data demonstrate Verzenio’s long-term impact on cancer recurrence in high-risk early breast cancer October 27, 2023Vol.49 No.40
Clinical Roundup mRNA delivered by extracellular vesicles induces immunotherapy response in glioblastoma October 27, 2023Vol.49 No.40
Clinical Roundup Perioperative Opdivo-based regimen shows significant improvement in EFS for resectable NSCLC October 20, 2023Vol.49 No.39
Clinical Roundup MRI scan could predict radiation side effects for prostate cancer October 20, 2023Vol.49 No.39
Clinical Roundup UC, UNC, Duke to collaborate on large prospective study investigating effect of cancer on stroke risk October 20, 2023Vol.49 No.39
